Profile
Alexey Nechaev served as the Head of Corporate Strategy, Mergers & Acquisitions at Evraz Group SA in 2008.
He also served as an Independent Director at Cleveland BioLabs, Inc. from 2016 to 2018.
Nechaev received his undergraduate degree from Higher School of Economics in 2008 and his graduate degree from The New Economic School in 2011.
Former positions of Alexey Nechaev
| Companies | Position | End |
|---|---|---|
| STATERA BIOPHARMA, INC. | Director/Board Member | 2018-08-09 |
| EVRAZ GROUP SA (EDR) | Corporate Officer/Principal | 2008-10-31 |
Training of Alexey Nechaev
| The New Economic School | Graduate Degree |
| Higher School of Economics | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Cleveland BioLabs, Inc.
 Cleveland BioLabs, Inc. Pharmaceuticals: MajorHealth Technology Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY. | Health Technology |
Evraz Group SA
 Evraz Group SA SteelNon-Energy Minerals Evraz Group SA engages in mining operations. It extracts iron ore, steel, coal, and vanadium. It also engages in the logistics and trading activities. The company was founded in 1992 and is headquartered in the Luxembourg. | Non-Energy Minerals |
- Stock Market
- Insiders
- Alexey Nechaev
